Filter By Category
Archives
Share on -
EDRECOLOMAB
Generic Name: EDRECOLOMAB
ABSTRACT -
Edrecolomab is a monoclonal antibody directed against epithelial cell adhesion molecule (EpCAM), historically investigated in colorectal and other epithelial cancers.
DOSAGE -
IV oncology dosing is product- or protocol-specific and requires infusion monitoring.
SIDE EEFECTS -
- Infusion reactions
- Fever and chills
- Nausea or vomiting
- Rash
- Fatigue
ALLERGIC REACTIONS -
These symptoms may indicate an allergic reaction and require medical attention.
- Urticaria, bronchospasm, hypotension, angioedema, or anaphylaxis
DRUG INTEACTIONS-
- Other anticancer therapies may increase overlapping toxicity
- Immunosuppressants may alter immune-mediated efficacy
- Live vaccines should generally be avoided during significant immunosuppression
PREAUTONS–
- Monitor infusion reactions, organ function, infection, and tumor-related symptoms
- Use caution in patients with severe hypersensitivity history
- Pregnancy risk requires oncology counseling
WARNINGS –
- Serious infusion reactions and immune-mediated toxicity may occur
Share on -
. Developed by